U.S. Patent Office Issues Notice of Allowance to Dermisonics

Dermisonics, a medical device company with its focus on the development of an ultrasonically assisted transdermal drug-delivery technology, announced that the U.S. Patent and Trademark Office has issued a notice of allowance for the approval of the most substantial patent claims for the Medi-Cap, a groundbreaking transdermal drug-delivery device.

MENAFN (http://menafn.com/qn_news_story.asp?StoryId=CqNHiWbKbmti0yJq4ndC)